The Effect of Intermittent Fasting on Brain Health
Time Restricted Eating for Prevention of Age-related Vascular Cognitive Decline in Older Adults
2 other identifiers
interventional
32
1 country
1
Brief Summary
The central hypothesis of this study is that closer adherence to time restricted eating (TRE) will improve endothelial function, neurovascular (NVC) responses, resulting in improved cognitive performance, potentially through activation of SIRT1-dependent vasoprotective pathways.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 24, 2023
CompletedFirst Posted
Study publicly available on registry
August 31, 2023
CompletedStudy Start
First participant enrolled
May 13, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 2, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 2, 2026
CompletedFebruary 6, 2026
February 1, 2026
1.7 years
August 24, 2023
February 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in neurovascular coupling using functional near infrared spectroscopy (fNIRS)
Functional near infrared spectroscopy (fNIRS) will be performed during the cognitive n-back task. fNIRS approach generates data that represent a relative change in oxygenated and deoxygenated hemoglobin measured over the cortical brain tissues. Neurovascular coupling will be evaluated as a change in oxy- and deoxy-hemoglobin between before and after completion of study.
baseline, up to 6 months
Change in neurovascular coupling using the dynamic retinal vessel analysis
Flicker light-induced dilation of the retinal vessels (percentage increase over baseline diameter) will be measured in the right or left eye of each study participant using the Dynamic Vessel Analyzer (DVA, IMEDOS Systems, Jena, Germany). The change in retinal vessel diameters is tracked and reported as a %change from baseline, before and after completion of study.
baseline, up to 6 months
Change in EEG spectra
EEG signal will be collected to generate spectral data. These data will be used for comparison of EEG activity between before and after treatment. Units of measure - power spectral density. Reported as a %change from baseline, before and after completion of study.
baseline, up to 6 months
Secondary Outcomes (16)
Change in microvascular endothelial function
baseline, up to 6 months
Change in arterial stiffness
baseline, up to 6 months
Change in Glycocalyx - perfused boundary region
baseline, up to 6 months
Change in capillary density
baseline, up to 6 months
Change in red blood cell velocity
baseline, up to 6 months
- +11 more secondary outcomes
Study Arms (1)
Time restricted eating
EXPERIMENTALnot more than 10 hrs. eating window daily goal for 6 months
Interventions
not more than 10 hrs. eating window daily goal for 6 months
Eligibility Criteria
You may qualify if:
- Age ≥55 and ≤80 years of age
- Adequate hearing and visual acuity to participate in the examinations
- Ability to read and write in English
- Competence to provide informed consent.
- Mini Montreal Cognitive Assessment ≥12
- Mini Nutritional Assessment ≥12
You may not qualify if:
- Vision or hearing impairment that would impair the ability to complete study assessments
- Active CNS disease including multiple sclerosis, uncontrolled seizures, active brain cancer
- Cerebrovascular accident other than TIA within 60 days prior to Visit 0
- Major psychiatric disease, including major depression not currently controlled on medications, alcohol or drug abuse
- Diabetics prescribed sulfonylureas, meglitinides, and insulin
- Any other medical condition which, in the opinion of investigator, would render the patient inappropriate or too unstable to complete the study protocol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Oklahomalead
- National Institute on Aging (NIA)collaborator
Study Sites (1)
Translational GeroScience Laboratory
Oklahoma City, Oklahoma, 73117, United States
Related Publications (2)
da C Pinaffi-Langley AC, Szarvas Z, Peterfi A, Kaposzta Z, Mukli P, Shahriari A, Muranyi M, Pinto CB, Owens CD, Adams C, Karfonta B, Rohan M, Tarantini S, Yabluchanskiy A. Time-restricted eating for prevention of age-related vascular cognitive decline in older adults: A protocol for a single-arm open-label interventional trial. PLoS One. 2024 Dec 9;19(12):e0314871. doi: 10.1371/journal.pone.0314871. eCollection 2024.
PMID: 39652561BACKGROUNDda C Pinaffi-Langley AC, Pinto CB, Mukli P, Peterfi A, Kaposzta Z, Owens CD, Szarvas Z, Muranyi M, Adams C, Shahriari A, Balasubramanian P, Ungvari Z, Csiszar A, Conley S, Hord NG, Anderson L, Tarantini S, Yabluchanskiy A. Energy metabolism dysregulation, cerebrovascular aging, and time-restricted eating: Current evidence and proof-of-concept findings. PNAS Nexus. 2024 Nov 8;3(11):pgae505. doi: 10.1093/pnasnexus/pgae505. eCollection 2024 Nov.
PMID: 39584020BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andriy Yabluchanskiy, MD, PhD
University of Oklahoma
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 24, 2023
First Posted
August 31, 2023
Study Start
May 13, 2024
Primary Completion
February 2, 2026
Study Completion
February 2, 2026
Last Updated
February 6, 2026
Record last verified: 2026-02